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measures prevented the misidentification of contami-
nating, undifferentiated myoblasts which quite likely
contributed to the confusion regarding the activity
of microtubule depolymerizing agents in myogenic de-
differentiation.
More recent studies have identified other agents,
which seem more certain to induce dedifferentiation in
vitro. ‘‘Reversine’’ is a small molecule that can trigger
myoblasts, which are lineage committed, to dedifferen-
tiate into more multipotent progenitor-type cells which
are capable of being directed to differentiate not only
into osteoblasts but adipocytes as well [15]. Such dis-
coveries have not been limited to small molecules: Chen
et al. recently showed that ciliary neurotrophic factor
(CNTF) can similarly induce myoblasts to adopt a
multipotent phenotype capable of redifferentiating into
adipocytes, glial, and neuronal cells [16]. It remains
to be determined whether reversine and CNTF share a
common mechanism or have an effect on the more
differentiated myotube. Perhaps a combination of a
microtubule depolymerizer and reversine might accom-
plish that which the former, and agents like it, alone
cannot—complete cellularization and dedifferentiation
of mammalian myotubes.
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of Ketoreduction
In this issue of Chemistry & Biology, Leadlay and co-
workers [1] report overproduction of a number of keto-
reductase domains frommodular polyketide synthases.
These discrete enzymes allow the stereochemistry of
polyketide ketoreduction to be studied in isolation.
The well-studied 6-deoxyerythronolide B synthase
(DEBS) catalyzes formation of the macrolactone core
of erythromycin [2]. DEBS contains a module for each
of the six cycles in the chain assembly process. This
modular organization is found in many other important
polyketide synthases (PKSs) [3]. In a typical module,
an acyl transferase (AT) loads an extender unit onto
the phosphopantetheine thiol of an acyl carrier protein
(ACP). The extender condenses with an acyl chain that
is thioester-linked to the active site cysteine of a keto-
synthase (KS). The resulting b-ketoacyl-ACP may bereduced to a b-hydroxyacyl intermediate by a keto-
reductase (KR) and may be processed further by dehy-
dratase and enoyl reductase enzymes. An entire PKS
consists of a series of modules that are housed within
large multienzyme polypeptides. A frequently occurring
module catalyzes the incorporation of propionate, and
reduction of the b-ketone group to an alcohol. The 2-
methyl-3-hydroxyacyl thioester product has two new
chiral centers. All four combinations of methyl and alco-
hol stereochemistry [(2R, 3S), (2S, 3R), (2R, 3R), (2S, 3S)]
can appear in nascent polyketide chains. It is unclear
how these different stereochemical outcomes are
achieved by PKS modules of apparently similar domain
composition and sequence.
Detailed studies on DEBS and truncated derivatives
have given deep insights into the stereochemistry of
polyketide chain extension. All six modules use (2S)-
methylmalonyl-CoA as a source of activated propionyl
extender units [4]. In the cycle catalyzed by DEBS
module 2, condensation proceeds with inversion of ste-
reochemistry, so that the initial product is (2R)-
2-methyl-3-ketoacyl-ACP2 [5]. With DEBS module 1, the
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1061Figure 1. Reduction of Diketide Substrates
by Isolated KR Domains In Vitro
The yields of each hydroxy diketide are ex-
pressed as the percentage of the total prod-
ucts reduced by each KR. Numbers in bold
type indicate the product expected for each
KR, based on the inferred reaction in the
native PKS. The B-type TYLS KR1 and DEBS
KR1 selected their natural substrates from the
racemic mixture and catalyzed ketoreduction
strictly in the normal sense. The A-type DEBS
KR2, KR5, and KR6 domains reduced their
natural (2R) substrate analog correctly but
showed a strong preference for the unnatural
(2S) stereoisomer, reducing it mostly in the
correct stereochemical sense. DEBS KR2
reduced a high proportion of this unnatural
substrate in the wrong stereochemical sense.methyl-bearing carbon atom [C-2 of the original (2S)-
methylmalonyl extender] is epimerized at some stage
after acylation of the PKS. Together with inversion dur-
ing condensation, this epimerization would give (2S)-
2-methyl-3-ketoacyl-ACP1, in which the methyl group
has the stereochemistry seen in the final macrolactone
ring [5]. Exactly how the epimerization is achieved is un-
certain. It may occur postcondensation on the 2-methyl-
3-ketoacyl-ACP. With synthetic 2-methyl-3-ketoacyl-N-
acetylcysteamine (NAC) thioesters, the diketide C-2
proton is made acidic by the b-ketone and thioester car-
bonyl groups and exchanges rapidly in D2O [6]. PKS
modules do not contain epimerase domains and it has
been suggested that they suppress or favor epimeriza-
tion by restricting or allowing access of the b-ketoester
to water [6]. Epimerization after condensation could
mean that both unepimerized (2R) and epimerized (2S)
chains are available to downstream enzymes such as
the KR or the KS of the next module, which would then
contribute to determining the methyl stereochemistry
by selecting only 2S stereoisomers for further process-
ing. While available evidence favors this view [7], it is still
possible that epimerization is brought about by some
other unexpected mechanism. Although b-ketone re-
duction would most likely prevent further C-2 epimeri-
zation, it is not essential for fixing the methyl
stereochemistry. DEBS module 3 transfers an epimer-
ized, but unreduced, (2S) 2-methyl-3-ketoacyl chain to
the KS of module 4.
The KR domains of modular PKSs generate the two
types of alcohol stereochemistry by adding hydride ions
to opposite faces of b-ketone groups [8, 9]. B-type
KRs generate products with the same alcohol stereo-
chemistry as the (3R)-3-hydroxyacyl-ACP chains that
feature in fatty acid biosynthesis. A-type KRs give the
same alcohol stereochemistry as the (3S)-3-hydroxy-
acyl-CoA intermediates in fatty acid breakdown [10].
B-type KRs have a few fairly well-conserved amino acid
residues that are absent from A-type KRs, whereas A-
type KRs have a conserved tryptophan residue that is
absent from B-type KRs [10, 11].
Cane, Khosla, and coworkers reversed the stereo-
chemistry of an alcohol in a polyketide product by re-placing the A-type DEBS KR2 with the B-type KR4
from the rapamycin PKS (RAPS) [12]. The transplanted
RAPS KR4 still carried out B-type ketoreduction even
when faced with a b-ketoester that differed from its nor-
mal substrate at C-2 and C-4. Further investigations
have yielded more complex results, particularly studies
on A-type KRs in epimerizing modules [6, 7, 13]. The in-
terpretation of these findings is complicated by the un-
certainties surrounding the epimerization step. In their
latest study [1], Leadlay and coworkers make a signifi-
cant advance by overproducing individual KR domains
in an active form. To a large extent, this approach sep-
arates the ketoreduction step from the unknowns of C-2
epimerization. Five different KR domains were overpro-
duced. With each of these KRs, a racemic mixture of
(2RS)-2-methyl–3-ketopentanoyl-NAC thioesters was
used to investigate the intrinsic stereoselectivity (ability
to discriminate between 2R and 2S substrates) and ste-
reospecificity (ability to catalyze ketoreduction in a sin-
gle direction). The results are summarized in Figure 1.
The isolated DEBS KR1 acted only on its natural 2S
diketide substrate and carried out stereospecific ketor-
eduction to generate the (2S, 3R) thioester as sole prod-
uct. The KR1 from the tylosin PKS also acted almost
exclusively on its natural diketide, in this case 2R, and
carried out stereospecific ketoreduction to give a (2R,
3R) product. These two B-type KRs were capable of
selecting their natural substrates from the racemic mix-
ture and catalyzed ketoreduction in the same sense as
their counterparts embedded in intact PKS modules.
The intrinsic properties of these isolated domains are
consistent with the hypothesis that these KRs can de-
termine the methyl stereochemistry and the alcohol ste-
reochemistry in a 2-methyl-3-hydroxyacyl intermedi-
ate [6].
The results with the three A-type KRs were less
straightforward. During biosynthesis of 6-deoxyerythro-
nolide B (6-dEB), DEBS KR2, KR5, and KR6 domains re-
duce 2R substrates to (2R, 3S) products. The isolated
DEBS KR2, KR5, and KR6 reduced the analogs of their
natural substrates stereospecifically, generating (2R,
3S) products from the 2R substrates. A surprising find-
ing was that with all three of these isolated KRs, most
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unnatural 2S stereoisomer (Figure 1). DEBS KR5 and
KR6 reduced this ‘‘incorrect’’ 2S substrate mostly, but
not completely, in the normal sense to give the (2S,
3S) product. DEBS KR2 reduced a significant proportion
of the unnatural substrate in the wrong stereochemical
sense, to give the (2S, 3R) diketide as 20% of the total
reduced products.
These results seem to suggest that a strong prefer-
ence for 2S substrates is itself an intrinsic property of
A-type KRs. During 6-dEB biosynthesis, the DEBS
KR2, KR5, and KR6 domains are housed in nonepime-
rizing modules, and by default would encounter only
2R substrates, which they reduce stereospecifically to
give (2R, 3S) products. In an epimerizing module, a pref-
erence for (2S)-2-methyl 3-ketoesters could assist the
KR in selecting epimerized rather than unepimerized
substrates, and to produce (2S, 3S)-2-methyl-3-hydrox-
yacyl intermediates. Further work will be required to
ascertain whether DEBS KR2, KR5, and KR6 show dif-
ferent stereoselectivity and more rigorous stereospeci-
ficity given longer chain ketoacyl thioesters that more
closely resemble their natural substrates.
The tendency of the isolated A-type KRs to give
mostly (2S, 3S) products was not revealed by previous
studies where these enzymes were constrained within
multienzyme polypeptides of unimodular and bimodular
DEBS PKSs [7, 13]. It is possible that in intact modules,
the ACP-KR interaction could influence the stereo-
chemical outcome of A-type ketoreduction. With bi-
modular systems, DEBS KS domains may not accept
an (2S, 3S) anti diketide generated by a previous module
[14], so that relatively minor products are preferentially
incorporated into triketide lactones [7].
The results with isolated KR domains may also be use-
ful in investigating C-2 epimerization. This latest work
[1] adds to the evidence [6] that in the first cycle of
6-dEB biosynthesis, DEBS KR1-catalyzed ketoreduc-
tion cannot happen without prior C-2 epimerization.
Specific inactivation of the epimerase should then abol-
ish KR1 activity against b-ketoesters synthesized by
KS1 and ACP1, but not against synthetic substrates such
as decalones or (2S)-2-methyl-3-ketoacyl thioesters.
Regions of module 1 that are essential for C-2 epimeriza-
tion might then be identified by mutagenesis, or by
exchanging stretches of sequence with equivalentregions from a nonepimerizing module. This work could
be attempted with the KR2-deleted derivative of DEBS1-
TE [6] or the moderately active diketide synthase based
on DEBS module 1 [15]. With their work on isolated KR
domains, Siskos et al. provide a new avenue for dissect-
ing the stereochemical mechanisms involved in polyke-
tide biosynthesis.
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